Clover Health (CLOV) Joins Russell 3000 Index, Boosting Visibility

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of Goldman Sachs’ top penny stock picks. On June 30, Clover Health announced its inclusion in the Russell 3000 Index. The move was effected after the U.S. market opened on the same day. The company’s inclusion was part of the 2025 Russell Indexes annual reconstitution.

Membership in the Russell 3000 Index automatically grants Clover Health inclusion in either the large-cap Russell 1000 Index or the small-cap Russell 2000 Index. The direction this goes depends on the company’s specific market capitalization ranking. It will also be included in the relevant growth and value style indexes.

CEO Andrew Toy stated the milestone demonstrates the company’s continued commitment to building relationships with investors. Being added to the indexes, he said, enhances their visibility as they work toward their goals and long-term plans.

Clover Health Investments, Corp. (NASDAQ:CLOV) is a U.S.-based healthcare technology company. It offers Medicare Advantage insurance plans and operates Clover Assistant, a software platform that helps physicians manage chronic diseases and improve patient outcomes.

While we acknowledge the potential of CLOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Nuclear Energy Stocks to Invest in for the Next Decade and 10 Best Healthcare Penny Stocks to Buy According to Analysts.

Disclosure: None. This article is originally published at Insider Monkey.